Approximately 2.3 million patients in the world suffer from multiple sclerosis (MS). 20 674 MS patients were registered in 2012 in Ukraine, representing 55.3 cases per 100 thousands of population [4] . In the Volyn region, the prevalence of MS on 01.01.2013 is 101.0 cases per 100 thousand population and is the largest among of the regions [2] . According to the study MSIF (Multiple Sclerosis International Federation) 2013, primary clinical manifestations of MS are sensitive (40%), visual (30%), motor (39%), cognitive (10%), pain (15%), sexual (20%) disorders. About 30% of patients at the onset of MS experience fatigue, 24% -balance disorders, 17% -a violation of urination. These findings are ambiguous, because among the residents of some countries that participated in the registry, problems of dysfunction of pelvic organs and sexual disorders are the topics which hareless discussed than a visual or motor disorders [8] .
Many studies have found that age of debut, its clinical symptoms, the presence and duration of complete remission after the first symptoms of the disease are possible predictors of subsequent disease progression and the rate of disability. Typical of most studies is the predominance of onset of the disease between the ages of 20 and 40 years (70% of all cases) [7] . Only visual (optic neuritis) [9] or sensory disturbances as the initial manifestation of the disease is a sign for favorable further prognosis [6] . Late debut aged over 45 years is characterized by a high index of progression and poor prognosis regarding quick disability that is likely due to the more active neurodegenerative processs in this age group [5] . There are observations that patients with pyramidal or pelvic disorders at onset of the disease are at increased risk of a rapid deterioration in neurological deficit and achievement of secondary progressive stages of MS [6] . Problems regarding the prognostic value of the duration and completeness of remission have been widely discussed in the literature.
Research over the past decades proves the view that long-term remission after the debut of disease should be regarded as a subclinical stage of continuous course of autoimmune process that leads to the disruption of adaptive-compensatory mechanisms due to the lack of adequate immunosuppressive therapy in such patients. As a result, the disease transforms into progressive forms [3] . The rate of relapse in the first year is not considered a predictor of future course of disease. More important for the prognosis are clinical features of relapses, unfavorable sign is the presence of a pyramidal or pelvic disorders [1] .
Purpose: to analyze the age and clinical features of debut of MS in the Volyn cohort of patients.
Materials and methods. The Volyn registry of patients with MS was established in Volyn regional hospital in 2012. 825 patients were registered in Volyn region as of 01.01.13. In order to study the characteristics of MS in Volyn region, questionnaires were sent to patients that included queries relating to age of onset of the disease, age of diagnosis, symptoms that were the first manifestations of the disease, the availability of complete remission in early MS, time, expired from debut to the disappearance of complete remissions. The results obtained from 227 respondents, including 153 females and 73 males, mean age 43±10.6 years. Data were entered into an electronic database and were processed using computer programs Excel and Statistica 6.0.
Results. The mean age of onset of MS was 29.5±9.4 years , the mean age of diagnosis was 33.2±9.5years.
It was offered patients to choose among listed symptoms those which they experienced at the onset of disease. The frequency of occurrence of certain disorders in absolute numbers and percentage of total respondents indicated in the Thus, the most common symptoms of debut of MS were gait disturbance and weakness of the limbs. Most rarely at the initial stage of disease, patients indicated the presence of facial asymmetry, violations of sensitivity and color perception, restriction of visual fields, speech disorders.The mean age of onset of MS among those who reported about urinary and bowel dysfunction, speech disorders, pain of low back,limbs or face at the debut of disease was higher compared to patients who did not noted these symptoms .
In Table 2 is shown the frequency of occurrence of each of these symptoms in absolute numbers and percentages in groups depending on the age of onset of MS (till 25 years, from 25 years inclusive -till 40 years of age, from 40 years inclusive).
Found that patients with the onset of MS till 25 years more often complained of feeling of constant fatigue, depression or euphoria, decrease in mentation at the initial stage of disease compared to patients with more recent debut of MS. There is a gradual decrease in the percentage of patients who noted these symptoms at the onset of the disease with increasing age of onset of MS. In contrast, patients in whom the disease began after age 40, often pointed to dysfunction of the pelvic organs, disorders of speech, pain in the extremities, back, face. The percentage of patients who report the presence of these disorders in their early disease increases with age debut. In the age group with the onset of MS from 25 to 40 years, respondents more likely than in other groups pointed to the occurrence of numbing sensation or tingling in any part of the body at the early stage of disease.
99 of 227 (44%) of respondents noted remission at the beginning of disease, during which were completely healthy. 36 of 227 patients (16%) noted the presence of complete remission and so far, 168 (74%) indicated the presence of certain signs of MS in a period of remission. The mean duration of remission indicated by patients was 1 year 4 months, minimum remission lasted 1 month, maximum remission lasted 20 years. The mean time from onset of MS to disappearance of complete remission was 5 years±4 years.
Conclusions. This project is the first region wide large-scale MS survey, covering approximately 1/4 of patients, according to our estimates. The results identify the features of age and primary manifestations of MS in Volyn population. The more common occurrence of pelvic dysfunction, 1 -statistically significant differences were reached between the second and the first and the second and the third groups of patients; 2 -statistically significant difference was not reached; 3 -statistically significant difference was reached between the first and the third group of patients.
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